Drawing for BESTEA THERAPY

USPTO serial 85570886

BESTEA THERAPY

Reviewed by CopyMark Law Group

Reg. 4249430Status 710
Filing date
Status date
Registration date
Nov 27, 2012
Examiner
CARLYLE, SHAUNIA P
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with BESTEA THERAPY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005bee pollen for use as a dietary food supplement; beverages containing chlorophyll for use as a nutritional supplement; dietary and nutritional supplements; dietary and nutritional supplements containing herbs and minerals; dietary and nutritional supplements for endurance sports; dietary and nutritional supplements used for weight loss; dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; dietary food supplements; dietary supplement beverage for sleep, eye sight, vital organs, longevity, beauty, health, emotional and mental health, cleansing and well-being; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; dietary supplemental drinks; dietary supplements for controlling cholesterol; dietary supplements for human consumption; dietary supplements for pets; dietary supplements for pets in the nature of a powdered drink mix; dietary supplements for treatment of claustrophobia; dietary supplements for urinary health; dietary supplements for sleep, eye sight, vital organs, longevity, beauty, health, emotional and mental health, cleansing and well-being; herbal supplements; herbal supplements for sleeping problems; herbal supplements for sleep, eye sight, vital organs, longevity, beauty, health, emotional and mental health, cleansing and well-being; liquid nutritional supplement; liquid vitamin supplements; natural herbal supplements; natural supplements for treating candida; natural supplements for treating depression and anxiety; natural supplements for treating erectile dysfunction; nutraceuticals for use as a dietary supplement; nutraceuticals for use as a dietary supplement for sleep, eye sight, vital organs, longevity, beauty, health, emotional and mental health, cleansing and well-being; nutritional supplement for eliminating toxins from the body; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplements; pharmaceutical preparations for sleep, eye sight, vital organs, longevity, beauty, health, emotional and mental health, cleansing and well-being; pollen dietary supplements; vitamins and dietary food supplements for animals; weight management supplementsSECTION 8 - CANCELLEDMar 11, 2012

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 28, 2019C8..CANCELLED SEC. 8 (6-YR)—
Nov 27, 2017REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 27, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 11, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 11, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 22, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 9, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 9, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 26, 2012XAECEXAMINER'S AMENDMENT ENTERED—
Jul 25, 2012ALIEASSIGNED TO LIE—
Jul 25, 2012GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 25, 2012GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 25, 2012CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 23, 2012GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 23, 2012GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 23, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 21, 2012DOCKASSIGNED TO EXAMINER—
Mar 27, 2012MPMKNOTICE OF PSEUDO MARK MAILED—
Mar 26, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 19, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance